Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 8 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Indications for Dabrafenib and Trametinib Your NCI: Top Priorities from AACR 2026 Pesticide Usage, in Particular of Picloram, Associated with Early Onset Colorectal Cancer MOST POPULAR Concurrent Intrathecal and Intravenous Nivolumab is Safe and Feasible with Preliminary... April 12, 2023 Reunión anual de la American Society of Clinical Oncology de 2023:... May 25, 2023 For Hairy Cell Leukemia, Drug Combination Leads to Long-Lasting Remissions June 3, 2021 Cancer in My Community: Bringing Palliative Care to People With Cancer... February 21, 2023 Load more HOT NEWS Ivosidenib and Azacitidine Combination Shows Significant Clinical Benefit in Patients with... How People With Cancer Can Make the Most of Televisits Foodie Friday: Butternut Squash Macaroni Casserole Researchers Create Modified Antibodies to Target RAS and p53 in Cancer